Autoimmune and paraneoplastic channelopathies

Area of Science:

• Neurology
• Immunology
• Neuroscience

Background:

• Myasthenia gravis is caused by antibodies against muscle acetylcholine receptors (AChR).
• Research has expanded to identify other neurological disorders linked to autoantibodies.
• Several neuromuscular disorders involve antibodies targeting ligand- or voltage-gated ion channels.

Purpose of the Study:

• To review the landscape of antibody-mediated neurological disorders.
• To discuss the role of ion channel antibodies in neuromuscular and CNS disorders.
• To explore current and future treatment strategies for autoimmune channelopathies.

Main Methods:

• Literature review of antibody-mediated neurological disorders.
• Analysis of the mechanisms of autoantibody action on ion channels.
• Summary of therapeutic approaches for autoimmune channelopathies.

Main Results:

• Antibodies against ion channels are implicated in Lambert-Eaton syndrome, acquired neuromyotonia, and autoimmune autonomic ganglionopathy.
• Ion channel antibodies are increasingly found in CNS disorders like encephalitis and ataxia.
• Pathogenic antibodies directly impair ion channel function, affecting synaptic transmission and neuronal excitability.

Conclusions:

• Autoimmune channelopathies are a significant group of disabling neurological disorders.
• Immunomodulatory therapies, including plasma exchange and immunosuppressants, are effective treatments.
• Further research is expected to uncover more ion channel antibodies and associated autoimmune channelopathies.